Abstract
In heart muscle, NADP-linked isocitrate dehydrogenase activity is particularly high when compared with that of the other representative NADPH-generating enzyme, glucose-6-phosphate dehydrogenase. Approximately 80% of cardiac NADP-linked isocitrate dehydrogenase activity originates in the mitochondria. Adriamycin inhibited the activity of both mitochondrial and cytoplasmic NADP-linked isocitrate dehydrogenase dose dependently but had no effect on glucose-6-phosphate dehydrogenase. The inhibition was kinetically distinguished as noncompetitive. Preincubation of crude cardiac enzyme preparations with adriamycin enhanced the inhibition time dependently for 45 min. However, there was no evidence to suggest that the metabolites of adriamycin produced in this system were active as inhibitors. Adria-mycin-binding protein was fractionated by affinity chromatography, but NADP-linked isocitrate dehydrogenase activity was not detected in this fraction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alp, P. R., Newsholme, E. A., and Zammit, V. A. 1976. Activities of citrate synthase and NAD-linked and NADP-linked isocitrate dehydrogenase in muscle from vertebrates and invertebrates. Biochem. J. 154:689–700.
Asbell, M. A., Schwartzbach, E., Bullock, F. J., and Yesair, D. W., 1972. Daunomycin and adriamycin metabolism via reductive glycosidic cleavage. J. Pharmacol. Ther. 182:63–69.
Atassi, G., and Tagnon, H. J. 1974. Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L 1210 leukemia. Europ. J. Cancer. 10:399–403.
Barry, T. A., and Rosenkrantz, H. 1962. The level of isocitric acid dehydrogenase in tissues of vitamin E-deficient rabbits. J. Nutr. 76:447–452.
Bert, E., and Bergmeyer, H. U. 1974. Isocitrate dehydrogenase. In: H. U. Bergmeyer, (ed.), Methods of Enzymatic Analysis, Vol. 2, pp. 624–627. Academic Press, New York.
Blum, R. H., and Carter, S. K. 1974. Adriamycin, a new anticancer drug with significant clinical activity. Ann. Intern. Med. 80:249–259.
Bonadonna, G., Monfardini, S., De Lena, M., and Rossai-Bellani, F. 1969. Clinical evaluation of adriamycin, a new antitumor antibiotic. Br. Med. J. 3:503–506.
Bristow, M. R., Thompson, P. D., Martin, R. P., Marson, J. W., Billingham, M. E., and Harrison, D. C. 1978. Early anthracycline cardiotoxicity. Am. J. Med. 65:823–832.
Crooke, S. T., Duvernay, V. H., Galvan, L., and Prestayko, A. W., 1978. Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses. Mol. Pharmacol. 14:290–298.
Dhalla, N. S., Fedelesova, M., and Toffler, I. 1971. Biochemical alterations in skeletal muscle of vitamin E deficient rats. Can. J. Biochem. 49:1202–1208.
Di Marco, A., Gaetani, M., and Scarpinate, B. 1969. Adriamycin (NSC-123, 127): A new antibiotic with antitumor activity. Cancer Chemother. Rep. [Part 1] 53:33–37.
Edwin, E. E., Diplock, A. T., Bunyan, J., and Green, J. 1961. Studies on vitamin E. Biochem. J. 79:91–104.
Gloch, G. H., and Mc Lean, P. 1953. Further studies on the properties and assay of glucose-6-phosphate dehydrogenase and 6 phosphogluconate dehydrogenase of rat liver. Biochem. J. 55:400–408.
Gortner, R. A., Jr., and Milano, A. F. 1963. Effect of tocopherol depletion on muscle nucleic acid and creatine levels in the frog. Am. J. Physiol. 204:168–170.
Gosolvez, M., Van Rossam, G. D. V., and Blanco, M. F., 1979. Inhibition of sodium-potassium activated adenosine 5′ triphosphate and ion transport by adriamycin. Cancer Res. 39:257–261.
Hatefi, Y., Jurtshuk, P., and Haavik, A. G. 1961. Studies on the electron transport system. XXXII. Respiratory control in beef heart mitochondria. Arch. Biochem. Biophys. 94:148–155.
Kajiwara, H., Shimamoto, F., and Nakagami, K. 1980. Aclacinomycin cardiomyopathy. In: Abstracts, 3rd Congress of Cardiac Metabolism, Kyoto, Japan, p. 20.
Lowry, O. H., Rosenbrough, N. J., Farr, A. L., and Randall, R. J. 1951. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265–275.
Lucacchini, A., Martini, C, Segnini, D., and Ronca, G. 1979. Evidence of soluble proteins binding adriamycin by affinity chromatography. Experientia. 35:1148–1149.
March, S. C., Parikh, I., and Cuatrecasas, P. 1974. A simple method for cyanogen bromide activation of agarose for affinity chromatography. Anal. Biochem. 60:149–152.
Myer, C. E., McGuire, W. P., Liss, R. H., Ifrim, I., Grotzinger, K., and Young, R. C. 1977. Adriamycin: The role of lipid peroxidation in cardiac toxicity and tumor response. Science 197:165–167.
Negishi, T., and Takahira, H. 1973. [The absorption, excretion, distribution and metabolism of adriamycin.] Kiso To Rinsho 7:425–431.
Olson, H. M., and Capen, C. C. 1977. Subacute cardiotoxicity of adriamycin in the rat. Lab. Invest. 37:386–394.
Trout, A., Campeneere, D. D., and De Duve, C. 1972. Chemotherapy through lysosomes with a DNA-daunomycin complex. Nature [New Biol.] 239:110–112.
Yasumi, M., Minaga, T., Nakamura, K., Kimura, I., Maeda, M., Yoneda, S., Kizu, A., and Ijichi, H. 1980. The studies on cardiotoxicity by adriamycin. In: Abstracts, 3rd Congress of Cardiac Metabolism, Kyoto, Japan, p. 19.
Yasumi, M., Minaga, T., Nakamura, K., Kizu, A., and Ijichi, H. 1980. Inhibition of cardiac NADP-linked isocitrate dehydrogenase by adriamycin. Biochem. Biophys. Res. Commun. 93:631–636.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Minaga, T., Yasumi, M., Nakamura, K., Kimura, I., Kizu, A., Ijichi, H. (1983). A Possible Mechanism of Adriamycin Cardiotoxicity. In: Chazov, E., Saks, V., Rona, G. (eds) Advances in Myocardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4441-5_22
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4441-5_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4443-9
Online ISBN: 978-1-4757-4441-5
eBook Packages: Springer Book Archive